Top

BMC Gastroenterology

Published in:

Open Access 01-12-2010 | Research article

Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy

Authors: Devidas Menon, Tania Stafinski, Heng Wu, Darren Lau, Clarence Wong

Published in: BMC Gastroenterology | Issue 1/2010

Abstract

Background

Recently, several new endoscopic treatments have been used to treat patients with Barrett's esophagus with high grade dysplasia. This systematic review aimed to determine the safety and effectiveness of these treatments compared with esophagectomy.

Methods

A comprehensive literature search was undertaken to identify studies of endoscopic treatments for Barrett's esophagus or early stage esophageal cancer. Information from the selected studies was extracted by two independent reviewers. Study quality was assessed and information was tabulated to identify trends or patterns. Results were pooled across studies for each outcome. Safety (occurrence of adverse events) and effectiveness (complete eradication of dysplasia) were compared across different treatments.

Results

The 101 studies that met the selection criteria included 8 endoscopic techniques and esophagectomy; only 12 were comparative studies. The quality of evidence was generally low. Methods and outcomes were inconsistently reported. Protocols, outcomes measured, follow-up times and numbers of treatment sessions varied, making it difficult to calculate pooled estimates.

The surgical mortality rate was 1.2%, compared to 0.04% in 2831 patients treated endoscopically (1 death). Adverse events were more severe and frequent with esophagectomy, and included anastomotic leaks (9.4%), wound infections (4.1%) and pulmonary complications (4.1%). Four patients (0.1%) treated endoscopically experienced bleeding requiring transfusions. The stricture rate with esophagectomy (5.3%) was lower than with porfimer sodium photodynamic therapy (18.5%), but higher than aminolevulinic acid (ALA) 60 mg/kg PDT (1.4%). Dysphagia and odynophagia varied in frequency across modalities, with the highest rates reported for multipolar electrocoagulation (MPEC). Photosensitivity, an adverse event that occurs only with photodynamic therapy, was experienced by 26.4% of patients who received porfimer sodium.

Some radiofrequency ablation (RFA) or argon plasma coagulation (APC) studies (used in multiple sessions) reported rates of almost 100% for complete eradication of dysplasia. But the study methods and findings were not adequately described. The other studies of endoscopic treatments reported similarly high rates of complete eradication.

Conclusions

Endoscopic treatments offer safe and effective alternatives to esophagectomy for patients with Barrett's esophagus and high grade dysplasia. Unfortunately, shortcomings in the published studies make it impossible to determine the comparative effectiveness of each of the endoscopic treatments.

Available only for authorised users

Tougas G, Chen Y, Hwang P, Liu MM, Eggleston A: Prevalence and impact of upper gastrointestinal symptoms in the Canadian population: findings from the DIGEST study. Domestic/International Gastroenterology Surveillance Study. Am J Gastroenterol. 1999, 94: 2845-2854. 10.1111/j.1572-0241.1999.01427.x.PubMed

Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Vieth M, Stolte M, Talley NJ, Agreus L: Prevalence of Barrett's esophagus in the general population: an endoscopic study. Gastroenterology. 2005, 129: 1825-1831. 10.1053/j.gastro.2005.08.053.PubMed

Esquivel RF, Boolchang V, Kumar N, Camargo L, Kim JL, Fass R, Sampliner RE: The prevalence of Barrett's esophagus in veteran patients with and without GERD symptoms undergoing outpatient colonoscopy [abstract]. Gastrointest Endosc. 2008, 67: AB172-10.1016/j.gie.2008.03.402.

Lao CD, Simmons M, Syngal S, Bresalier RS, Fortlage L, Normolle D, Griffith KA, Appelman HD, Brenner DE: Dysplasia in Barrett esophagus. Cancer. 2004, 100: 1622-1627. 10.1002/cncr.20149.PubMed

Hookey LC: Barrett's esophagus--who, how, how often and what to do with dysplasia?. Can J Gastroenterol. 2006, 20: 463-466.PubMedPubMedCentral

Yousef F, Cardwell C, Cantwell MM, Galway K, Johnston BT, Murray L: The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis. Am J Epidemiol. 2008, 168: 237-249. 10.1093/aje/kwn121.PubMed

Willich SN, Nocon M, Kulig M, Jaspersen D, Labenz J, Meyer-Sabellek W, Stolte M, Lind T, Malfertheiner P: Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa. Aliment Pharmacol Ther. 2006, 23: 371-376. 10.1111/j.1365-2036.2006.02763.x.PubMed

Amonkar MM, Kalsekar ID, Boyer JG: The economic burden of Barrett's esophagus in a Medicaid population. Ann Pharmacother. 2002, 36: 605-611. 10.1345/aph.1A309.PubMed

Green S, Tawil A, Barr H, Bennett C, Bhandari P, DeCaestecker J, Ragunath K, Singh R, Jankowski J: Surgery versus radical endotherapies for early cancer and high grade dysplasia in Barrett's oesophagus. Cochrane Library. 2009

10.

Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ: Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg. 2006, 93: 1084-1090. 10.1002/bjs.5373.PubMed

11.

Qureshi I, Nason KS, Luketich JD: Is minimally invasive esophagectomy indicated for cancer?. Expert Rev Anticancer Ther. 2008, 8: 1449-1460. 10.1586/14737140.8.9.1449.PubMed

12.

Phillips B, Ball C, Sackett D, Badenoch D, Straus S, Haynes B, Dawes M: Oxford Centre for Evidence-based Medicine levels of evidence and grades of recommendation. 2001, Oxford (UK): Oxford Centre for Evidence-based Medicine

13.

Hage M, Siersema PD, van DH, Steyerberg EW, Haringsma J, van d V, Grool TE, van Veen RL, Sterenborg HJ, Kuipers EJ: 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial. Gut. 2004, 53: 785-790. 10.1136/gut.2003.028860.PubMedPubMedCentral

14.

Kelty CJ, Ackroyd R, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW: Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation. Aliment Pharmacol Ther. 2004, 20: 1289-1296. 10.1111/j.1365-2036.2004.02277.x.PubMed

15.

Ragunath K, Krasner N, Raman VS, Haqqani MT, Phillips CJ, Cheung I: Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness. Scand J Gastroenterol. 2005, 40: 750-758. 10.1080/00365520510015737.PubMed

16.

Zoepf T, Alsenbesy M, Jakobs R, Apel D, Rosenbaum A, Riemann JF: Photodynamic therapy (PDT) versus argon plasma, coagulation (APC) for ablative therapy of Barrett's esophagus [abstract]. Gastrointest Endosc. 2003, 57: AB139-

17.

Dulai GS, Jensen DM, Cortina G, Fontana L, Ippoliti A: Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. Gastrointest Endosc. 2005, 61: 232-240. 10.1016/S0016-5107(04)02576-3.PubMed

18.

Sharma P, Wani S, Weston AP, Bansal A, Hall M, Mathur S, Prasad A, Sampliner RE: A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results. Gut. 2006, 55: 1233-1239. 10.1136/gut.2005.086777.PubMedPubMedCentral

19.

Shaheen NJ, Sharma P, Overholt BF, Wolfsen HC, Sampliner RE, Wang KK, Galanko JA, Bronner MP, Goldblum JR, Bennett AE, et al: Radiofrequency ablation in Barrett's esophagus with dysplasia. N Eng J Med. 2009, 360: 2277-2288. 10.1056/NEJMoa0808145.

20.

Reed MF, Tolis G, Edil BH, Allan JS, Donahue DM, Gaissert HA, Moncure AC, Wain JC, Wright CD, Mathisen DJ: Surgical treatment of esophageal high-grade dysplasia. Ann Thorac Surg. 2005, 79: 1110-1115. 10.1016/j.athoracsur.2004.09.006.PubMed

21.

Prasad GA, Wang KK, Buttar NS, Wongkeesong LM, Krishnadath KK, Nichols FC, Lutzke LS, Borkenhagen LS: Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology. 2007, 132: 1226-1233. 10.1053/j.gastro.2007.02.017.PubMedPubMedCentral

22.

Mackenzie G, Clark BR, Selvasekar C, Jamieson N, Novelli M, Thorpe S, Mosse C, Bown S, Lovat L: Photodynamic therapy with 5 aminolevulinic acid for high grade dysplasia in Barrett's esophagus: Longterm follow up of 51 patients [abstract]. Gastroenterology. 2005, 128: A238-10.1053/j.gastro.2004.11.026.

23.

Manner H, May A, Miehlke S, Dertinger S, Wigginghaus B, Schimming W, Kramer W, Niemann G, Stolte M, Ell C: Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation. Am J Gastroenterol. 2006, 101: 1762-1769. 10.1111/j.1572-0241.2006.00709.x.PubMed

24.

Fisher RS, Bromer MQ, Thomas RM, Cohen S, Krevsky B, Horwitz B, Glazier KD, Das K, Das KA: Predictors of recurrent specialized intestinal metaplasia after complete laser ablation. Am J Gastroenterol. 2003, 98: 1945-1951. 10.1111/j.1572-0241.2003.07628.x.PubMed

25.

Behrens A, May A, Gossner L, Gunter E, Pech O, Vieth M, Stolte M, Seitz G, Ell C: Curative treatment for high-grade intraepithelial neoplasia in Barrett's esophagus. Endoscopy. 2005, 37: 999-1005. 10.1055/s-2005-870352.PubMed

26.

Ortner MA, Zumbusch K, Liebetruth J, Ebert B, Fleige B, Dietel M, Lochs H: Is topical delta-aminolevulinic acid adequate for photodynamic therapy in Barrett's esophagus? A pilot study. Endoscopy. 2002, 34: 611-616. 10.1055/s-2002-33247.

27.

Ortner M, Zumbusch K, Liebetruth J, Ernst H, Weber J, Wirth J, Wedel S, Lochs H: Photodynamic therapy of Barrett's esophagus after local administration of 5-aminolaevulinic acid [abstract]. Gastroenterology. 1997, 112: A633-

28.

Ackroyd R, Kelty CJ, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MW: Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up. Endoscopy. 2003, 35: 496-501. 10.1055/s-2003-39676.PubMed

29.

Ackroyd R, Davis MF, Brown NJ, Stephenson TJ, Stoddard CJ, Reed MWR: Photodynamic therapy (PDT): a new treatment for Barrett's oesophagus [abstract]. Lasers Med Sci. 1997, 12: 292-

30.

Ackroyd R, Brown NJ, Davis MF, Stephenson TJ, Stoddard CJ, Reed MWR: Aminolaevulinic acid-induced photodynamic therapy in the treatment of dysplastic Barrett's oesophagus and adenocarcinoma. Lasers Med Sci. 1999, 14: 278-285. 10.1007/s101030050095.

31.

Mackenzie G, Selvasekar C, Clark BR, Novelli M, Thorpe S, Mosse C, Bown S, Lovat L: Randomised controlled trial of photodynamic therapy using low dose 5 aminolevulinic acid activated by red or green light for high grade dysplasia in Barrett's esophagus [abstract]. Gastroenterology. 2005, 128: A238-10.1053/j.gastro.2004.11.026.

32.

Peters F, Kara M, Rosmolen W, Aalders M, ten KF, Krishnadath K, van LJ, Fockens P, Bergman J: Poor results of 5-aminolevulinic acid-photodynamic therapy for residual high-grade dysplasia and early cancer in barrett esophagus after endoscopic resection. Endoscopy. 2005, 37: 418-424. 10.1055/s-2005-861198.PubMed

33.

van Hillegersberg R, Haringsma J, Ten Kate FJ, Tytgat GN, van Lanschot JJ: Invasive carcinoma after endoscopic ablative therapy for high-grade dysplasia in Barrett's oesophagus. Dig Surg. 2003, 20: 440-444. 10.1159/000072713.PubMed

34.

Barr H, Shepherd NA, Dix A, Roberts DJ, Tan WC, Krasner N: Eradication of high-grade dysplasia in columnar-lined (Barrett's) oesophagus by photodynamic therapy with endogenously generated protoporphyrin IX. Lancet. 1996, 348: 584-585. 10.1016/S0140-6736(96)03054-1.PubMed

35.

Gossner L, Stolte M, Sroka R, Rick K, May A, Hahn EG, Ell C: Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid. Gastroenterology. 1998, 114: 448-455. 10.1016/S0016-5085(98)70527-X.PubMed

36.

Gossner L, May A, Sroka R, Ell C: A new long-range through-the-scope balloon applicator for photodynamic therapy in the esophagus and cardia. Endoscopy. 1999, 31: 370-376. 10.1055/s-1999-31.PubMed

37.

Kashtan H, Umansky M, Birkenfeld S, Scherubl H, Haddad R, Greenberg R, Konikoff F: Photodynamic therapy of Barrett's esophagus with dysplasia using systemic aminolevulinic acid and a non-laser light source. A phase I/II study. Gastrointestinal Oncology. 2002, 4: 153-157. 10.1080/1475956021000017020.

38.

Mackenzie GD, Dunn JM, Novelli MR, Mosse S, Thorpe SM, Bown SG, Lovat LB: Preliminary results of a randomised controlled trial into the safety and efficacy of ALA versus photofrin photodynamic therapy for high grade dysplasia in Barrett's oesophagus [abstract]. Gut. 2008, 57: A14-

39.

Macrae FA, Rajesekaram R, Thomas R, Bhathal PS: Photodynamic therapy in high grade dysplasia in Barrett's oesophagus using 5 amino-laevulinic acid sensitization [abstract]. Gastrointest Endosc. 2004, 59: P252-10.1016/S0016-5107(04)01128-9.

40.

Mellidez JC, Mackenzie G, Selvasekar C, Novelli M, Thorpe S, Mosse C, Bown S, Lovat L: Reversal of Barrett's esophagus following photodynamic therapy using high dose 5 aminolevulinic acid activated by red or green laser light [abstract]. Gastroenterology. 2005, 128: A239-10.1053/j.gastro.2004.11.027.

41.

Laukka MA, Wang KK: Initial results using low-dose photodynamic therapy in the treatment of Barrett's esophagus. Gastrointest Endosc. 1995, 42: 59-63. 10.1016/S0016-5107(95)70245-8.PubMed

42.

Wang KK, Wongkeesong LM, Nourbakhsh A, Laukka M, Gutta K, Geller A, Balm R: Controlled trial of low dose photodynamic therapy for Barrett's esophagus [abstract]. Gastroenterology. 1997, 112: A676-

43.

Wang KK, Nijhawan P, Nourbakhsh A, Lutzke L, WongKeeSong M, Anderson M: Does residual Barrett's esophagus progress after photodynamic therapy? [abstract]. Gastroenterology. 1999, 116: A348-

44.

Javaid B, Watt P, Krasner N: Photodynamic therapy (PDT) for oesophageal dysplasia and early carcinoma with mTHPC (m-tetrahydroxyphenyl chlorin): a preliminary study. Lasers Med Sci. 2002, 17: 51-56. 10.1007/s10103-002-8266-5.PubMed

45.

Lovat LB, Jamieson NF, Novelli MR, Mosse CA, Selvasekar C, Mackenzie GD, Thorpe SM, Bown SG: Photodynamic therapy with m-tetrahydroxyphenyl chlorin for high-grade dysplasia and early cancer in Barrett's columnar lined esophagus. Gastrointest Endosc. 2005, 62: 617-623. 10.1016/j.gie.2005.04.043.PubMed

46.

Attila T, Kortan P, Kandel GT, Marcon N: Photodynamic therapy (PDT) for Barrett's esophagus with high grade dysplasia (BE-HGD) [abstract]. Gastrointest Endosc. 2005, 61: AB127-10.1016/S0016-5107(05)00760-1.

47.

Bronner M, Taylor S, Overholt B, Wang K, Burdick S, Lightdale C, Kimmey M, Nava H, Sivak M, Nishioka N, et al: Squamous overgrowth in a 5-year randomized phase III trial of photodynamic therapy using porfirmer sodium in ablation of high-grade dysplasia in Barrett's esophagus [abstract]. Gastroenterology. 2006, 130: A121-

48.

Keeley SB, Pennathur A, Gooding W, Landreneau RJ, Christie NA, Luketich J: Photodynamic therapy with curative intent for Barrett's esophagus with high grade dysplasia and superficial esophageal cancer. Ann Surg Oncol. 2007, 14: 2406-2410. 10.1245/s10434-007-9392-x.PubMed

49.

Overholt BF, Wang KK, Burdick JS, Lightdale CJ, Kimmey M, Nava HR, Sivak MV, Nishioka N, Barr H, Marcon N, et al: Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia. Gastrointest Endosc. 2007, 66: 460-468. 10.1016/j.gie.2006.12.037.PubMed

50.

Overholt BF, Panjehpour M, Halberg DL: Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results. Gastrointest Endosc. 2003, 58: 183-188. 10.1067/mge.2003.327.PubMed

51.

Overholt BF, Panjehpour M, Ayres M: Photodynamic therapy for Barrett's esophagus: cardiac effects. Lasers Surg Med. 1997, 21: 317-320. 10.1002/(SICI)1096-9101(1997)21:4<317::AID-LSM2>3.0.CO;2-T.PubMed

52.

Weiss AA, Wiesinger HAR, Owen D: Photodynamic therapy in Barrett's esophagus: Results of treatment of 17 patients. Can J Gastroenterol. 2006, 20: 261-264.PubMedPubMedCentral

53.

Wolfsen HC, Hemminger LL, Wallace MB, DeVault KR: Clinical experience of patients undergoing photodynamic therapy for Barrett's dysplasia or cancer. Aliment Pharmacol Ther. 2004, 20: 1125-1131. 10.1111/j.1365-2036.2004.02209.x.PubMed

54.

Yachimski P, Puricelli WP, Nishioka NS: Patient predictors of esophageal stricture development after photodynamic therapy. Clin Gastroenterol Hepatol. 2008, 6: 302-308. 10.1016/j.cgh.2007.12.001.PubMed

55.

Thomas T, Richards CJ, de Caestecker JS, Robinson RJ: High-grade dysplasia in Barrett's oesophagus: natural history and review of clinical practice. Aliment Pharmacol Ther. 2005, 21: 747-755. 10.1111/j.1365-2036.2005.02401.x.PubMed

56.

Attwood SE, Lewis CJ, Caplin S, Hemming K, Armstrong G: Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus. Clin Gastroenterol Hepatol. 2003, 1: 258-263. 10.1016/S1542-3565(03)00128-9.PubMed

57.

Basu KK: Effects of low-power argon plasma coagulation thermoablation of Barrett's epithelium on oesophageal motility. Eur J Gastroenterol Hepatol. 2006, 18: 733-737. 10.1097/01.meg.0000216928.91618.9a.PubMed

58.

Brand B, Porthun M, von Schrenck T, Matsui U, Bohnacker S, Jackle S, Thonke F, Seitz U, Soehendra N: Endoscopic Argonplasma coagulation for eradication of Barett's epithelium. Zentralbl Chir. 2000, 125: 437-442.PubMed

59.

Bright T, Watson DI, Tam W, Game PA, Astill D, Ackroyd R, Wijnhoven BP, Devitt PG, Schoeman MN: Randomized trial of argon plasma coagulation versus endoscopic surveillance for barrett esophagus after antireflux surgery: late results. Ann Surg. 2007, 246: 1016-1020. 10.1097/SLA.0b013e318133fa85.PubMed

60.

Dumoulin FL, Terjung B, Neubrand M, Scheurlen C, Fischer HP, Sauerbruch T: Treatment of Barrett's esophagus by endoscopic argon plasma coagulation. Endoscopy. 1997, 29: 751-753. 10.1055/s-2007-1004302.PubMed

61.

Familiari L: Endoscopic treatment of Barrett's epithelium with Argon Plasma Coagulation. Long-term follow-up. Minerva Gastroenterol Dietol. 2003, 49: 63-70.PubMed

62.

Ferraris R, Fracchia M, Foti M, Sidoli L, Taraglio S, Vigano' L, Giaccone C, Rebecchi F, Meineri G, Senore C, et al: Barrett's oesophagus: long-term follow-up after complete ablation with argon plasma coagulation and the factors that determine its recurrence. Aliment Pharmacol Ther. 2007, 25: 835-840. 10.1111/j.1365-2036.2007.03251.x.PubMed

63.

Formentini A: Treatment of Barrett's esophagus with argon plasma coagulation and antireflux surgery. A retrospective analysis. Hepato-Gastroenterology. 2007, 54: 1991-1996.PubMed

64.

Grade AJ, Shah IA, Medlin SM, Ramirez FC: The efficacy and safety of argon plasma coagulation therapy in Barrett's esophagus. Gastrointest Endosc. 1999, 50: 18-22. 10.1016/S0016-5107(99)70338-X.PubMed

65.

Madisch A, Miehlke S, Bayerdorffer E, Wiedemann B, Antos D, Sievert A, Vieth M, Stolte M, Schulz H: Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation. World J Gastroenterol. 2005, 11: 1182-1186.PubMedPubMedCentral

66.

Manner H, May A, Rabenstein T, Pech O, Nachbar L, Enderle MD, Gossner L, Ell C: Prospective evaluation of a new high-power argon plasma coagulation system (hp-APC) in therapeutic gastrointestinal endoscopy. Scand J Gastroenterol. 2007, 42: 397-405. 10.1080/00365520600898130.PubMed

67.

Manner H, May A, Faerber M, Rabenstein T, Ell C: Safety and efficacy of a new high power argon plasma coagulation system (hp-APC) in lesions of the upper gastrointestinal tract. Dig Liver Dis. 2006, 38: 471-478. 10.1016/j.dld.2006.03.022.PubMed

68.

Pedrazzani C, Catalano F, Festini M, Zerman G, Tomezzoli A, Ruzzenente A, Guglielmi A, de MG: Endoscopic ablation of Barrett's esophagus using high power setting argon plasma coagulation: a prospective study. World J Gastroenterol. 2005, 11: 1872-1875.PubMedPubMedCentral

69.

Pereira-Lima JC, Busnello JV, Saul C, Toneloto EB, Lopes CV, Rynkowski CB, Blaya C: High power setting argon plasma coagulation for the eradication of Barrett's esophagus. Am J Gastroenterol. 2000, 95: 1661-1668. 10.1111/j.1572-0241.2000.02197.x.PubMed

70.

Pinotti AC, Cecconello I, Filho FM, Sakai P, Gama-Rodrigues JJ, Pinotti HW: Endoscopic ablation of Barrett's esophagus using argon plasma coagulation: a prospective study after fundoplication. Dis Esophagus. 2004, 17: 243-246. 10.1111/j.1442-2050.2004.00415.x.PubMed

71.

Tigges H, Fuchs KH, Maroske J, Fein M, Freys SM, Muller J, Thiede A: Combination of endoscopic argon plasma coagulation and antireflux surgery for treatment of Barrett's esophagus. J Gastrointest Surg. 2001, 5: 251-259. 10.1016/S1091-255X(01)80045-7.PubMed

72.

Van Laethem JL, Jagodzinski R, Peny MO, Cremer M, Deviere J: Argon plasma coagulation in the treatment of Barrett's high-grade dysplasia and in situ adenocarcinoma. Endoscopy. 2001, 33: 257-261. 10.1055/s-2001-12803.PubMed

73.

Van Laethem JL, Cremer M, Peny MO, Delhaye M, Deviere J: Eradication of Barrett's mucosa with argon plasma coagulation and acid suppression: immediate and mid term results. Gut. 1998, 43: 747-751. 10.1136/gut.43.6.747.PubMedPubMedCentral

74.

Dumot JA, Vargo JJ, Zuccaro G, Falk GW, Frey L, Rice T: Results of cryospray ablation for esophageal high grade dysplasia (HGD) and intramucosal cancer (Imca) in high risk non-surgical patients [abstract]. Digestive Disease Week. 2008, M1304-

75.

Johnston MH: Cryoablation of Barrett's esophagus: A pilot study. Gastrointest Endosc. 2005, 62: 842-848. 10.1016/j.gie.2005.05.008.PubMed

76.

Wolfsen HC, Hemminger LL, Raimondo M, Woodward TA: Photodynamic therapy and endoscopic mucosal resection for Barrett's dysplasia and early esophageal adenocarcinoma. South Med J. 2004, 97: 827-830. 10.1097/01.SMJ.0000136265.34296.62.PubMed

77.

Michopoulos S, Tsibouris P, Bouzakis H, Sotiropoulou M, Kralios N: Complete regression of Barrett's esophagus with heat probe thermocoagulation: mid-term results. Gastrointest Endosc. 1999, 50: 165-172. 10.1016/S0016-5107(99)70219-1.PubMed

78.

Giovannini M, Bories E, Pesenti C, Moutardier V, Monges G, Danisi C, Lelong B, Delpero JR: Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer. Preliminary results in 21 patients. Endoscopy. 2004, 36: 782-787. 10.1055/s-2004-825813.PubMed

79.

Mino-Kenudson M, Brugge WR, Puricelli WP, Nakatsuka LN, Nishioka NS, Zukerberg LR, Misdraji J, Lauwers GY: Management of superficial Barrett's epithelium-related neoplasms by endoscopic mucosal resection - Clinicopathologic analysis of 27 cases. Am J Surg Pathol. 2005, 29: 680-686. 10.1097/01.pas.0000154129.87219.fa.PubMed

80.

Seewald S, Akaraviputh T, Seitz U, Brand B, Groth S, Mendoza G, He XK, Thonke F, Stolte M, Schroeder S, et al: Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma. Gastrointest Endosc. 2003, 57: 854-859. 10.1016/S0016-5107(03)70020-0.PubMed

81.

Tang SJ, Tang L, Jazrawi SF: Circumferential endoscopic mucosal resection of a 14-cm Barrett's dysplasia with the Duette mucosectomy device (with videos). Gastrointest Endosc. 2008, 68: 786-789. 10.1016/j.gie.2008.01.018.PubMed

82.

Barham CP, Jones RL, Biddlestone LR, Hardwick RH, Shepherd NA, Barr H: Photothermal laser ablation of Barrett's oesophagus: endoscopic and histological evidence of squamous re-epithelialisation. Gut. 1997, 41: 281-284. 10.1136/gut.41.3.281.PubMedPubMedCentral

83.

Bonavina L, Ceriani C, Carazzone A, Segalin A, Ferrero S, Peracchia A: Endoscopic laser ablation of nondysplastic Barrett's epithelium: Is it worthwhile?. J Gastrointest Surg. 1999, 3: 194-198. 10.1016/S1091-255X(99)80033-X.PubMed

84.

Bowers SP, Mattar SG, Waring PJ, Galloway K, Nasir A, Pascal R, Hunter JG: KTP laser ablation of Barrett's esophagus after anti-reflux surgery results in long-term loss of intestinal metaplasia. Potassium-titanyl-phosphate. Surg Endosc. 2003, 17: 49-54. 10.1007/s00464-001-8155-1.PubMed

85.

Ertan A, Zimmerman M, Younes M: Esophageal adenocarcinoma associated with Barretts esophagus - long-term management with laser-ablation. Am J Gastroenterol. 1995, 90: 2201-2203.PubMed

86.

Norberto L, Polese L, Angriman I, Erroi F, Cecchetto A, D'Amico DF: High-energy laser therapy of Barrett's esophagus: Preliminary results. World J Surg. 2004, 28: 350-354. 10.1007/s00268-003-7332-x.PubMed

87.

Salo JA, Salminen JT, Kiviluoto TA, Nemlander AT, Ramo OJ, Farkkila MA, Kivilaakso EO, Mattila SP: Treatment of Barrett's esophagus by endoscopic laser ablation and antireflux surgery. Ann Surg. 1998, 227: 40-44. 10.1097/00000658-199801000-00006.PubMedPubMedCentral

88.

Faigel DO, Lieberman DA, Weinstein WM, Fanning S, Fennerty MB, Sampliner RB: Effect of multipolar electrocoagulation on EUS findings in Barrett's esophagus. Gastrointest Endosc. 2002, 55: 23-26. 10.1067/mge.2002.120100.PubMed

89.

Kovacs BJ, Chen YK, Lewis TD, DeGuzman LJ, Thompson KS: Successful reversal of Barrett's esophagus with multipolar electrocoagulation despite inadequate acid suppression. Gastrointest Endosc. 1999, 49: 547-553. 10.1016/S0016-5107(99)70380-9.PubMed

90.

Montes CG, Brandalise NA, Deliza R, de Magalhaes AFN, Ferraz JGP: Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus. Gastrointest Endosc. 1999, 50: 173-177. 10.1016/S0016-5107(99)70220-8.PubMed

91.

Sampliner RE, Fennerty B, Garewal HS: Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results. Gastrointest Endosc. 1996, 44: 532-535. 10.1016/S0016-5107(96)70004-4.PubMed

92.

Bumgarner JM, Panjehpour M, Long M, Dellon ES, Overholt BF, Shaheen NJ: Comparison of catheter-based radiofrequency ablation and photodynamic therapy for Barrett's esophagus [abstract]. Gastroenterology. 2008, 134: A436-10.1016/S0016-5085(08)62035-1.

93.

Eldaif SM, Lin E, Singh KA, Force SD, Miller DL: Radiofrequency ablation of Barrett's esophagus: short-term results. Ann Thorac Surg. 2009, 87: 405-410. 10.1016/j.athoracsur.2008.11.043.PubMed

94.

Fleischer DE, Overholt BF, Sharma VK, Reymunde A, Kimmey MB, Chuttani R, Chang KJ, Lightdale CJ, Santiago N, Pleskow DK, et al: Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008, 68: 867-876. 10.1016/j.gie.2008.03.008.PubMed

95.

Ganz RA, Overholt BF, Sharma VK, Fleischer DE, Shaheen NJ, Lightdale CJ, Freeman SR, Pruitt RE, Urayama SM, Gress F, et al: Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc. 2008, 68: 35-40. 10.1016/j.gie.2007.12.015.PubMed

96.

Hernandez JC, Reicher S, Chung D, Pham BV, Tsai F, Disibio G, French S, Eysselein VE: Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy. 2008, 40: 388-392. 10.1055/s-2007-995747.PubMed

97.

Hubbard N, Velanovich V: Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus in patients with fundoplications. Surg Endosc. 2007, 21: 625-628. 10.1007/s00464-007-9199-7.PubMed

98.

Pouw RE, Gondrie JJ, Sondermeijer CM, Ten Kate FJ, van Gulik TM, Krishnadath KK, Fockens P, Weusten BL, Bergman JJ: Eradication of Barrett esophagus with early neoplasia by radiofrequency ablation, with or without endoscopic resection. J Gastrointest Surg. 2008, 12: 1627-1636. 10.1007/s11605-008-0629-1.PubMed

99.

Roorda AK, Marcus SN, Triadafilopoulos G: Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus. 2007, 20: 516-522. 10.1111/j.1442-2050.2007.00728.x.PubMed

100.

Sharma VK, Wang KK, Overholt BF, Lightdale CJ, Fennerty MB, Dean PJ, Pleskow DK, Chuttani R, Reymunde A, Santiago N, et al: Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007, 65: 185-195. 10.1016/j.gie.2006.09.033.PubMed

101.

Smith CD, Bejarano PA, Melvin WS, Patti MG, Muthusamy R, Dunkin BJ: Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc. 2007, 21: 560-569. 10.1007/s00464-006-9053-3.PubMed

102.

Sharma VK, Jae KH, Das A, Wells CD, Nguyen CC, Fleischer DE: Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol. 2009, 104: 310-317. 10.1038/ajg.2008.142.PubMed

103.

Vassiliou MC, von RD, Wiener DC, Gordon SR, Rothstein RI: Treatment of ultralong-segment Barrett's using focal and balloon-based radiofrequency ablation. Surg Endosc. 2009

104.

Velanovich V: Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: initial results and lessons learned. Surg Endosc. 2009, 23: 2175-2180. 10.1007/s00464-009-0364-z.PubMed

105.

Gondrie JJ, Pouw RE, Sondermeijer CMT, Peters FP, Curvers WL, Rosmolen WD, Krishnadath KK, Ten Kate F, Fockens P, Bergman JJ: Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy. 2008, 40: 359-369. 10.1055/s-2007-995567.PubMed

106.

Gondrie JJ, Pouw RE, Sondermeijer CM, Peters FP, Curvers WL, Rosmolen WD, ten KF, Fockens P, Bergman JJ: Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy. 2008, 40: 370-379. 10.1055/s-2007-995589.PubMed

107.

Ferguson MK, Naunheim KS: Resection for Barrett's mucosa with high-grade dysplasia: implications for prophylactic photodynamic therapy. J Thorac Cardiovasc Surg. 1997, 114: 824-829. 10.1016/S0022-5223(97)70087-4.PubMed

108.

Nguyen NT, Schauer P, Luketich JD: Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia. Surgery. 2000, 127: 284-290. 10.1067/msy.2000.103489.PubMed

109.

Romagnoli R: Outcomes of dysplasia arising in Barrett's esophagus: A dynamic view. J Am Coll Surg. 2003, 197: 365-371. 10.1016/S1072-7515(03)00417-4.PubMed

110.

Sujendran V, Sica G, Warren B, Maynard N: Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus. Eur J Cardiothorac Surg. 2005, 28: 763-766. 10.1016/j.ejcts.2005.08.018.PubMed

111.

Thomson BNJ, Cade RJ: Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus. ANZ J Surg. 2003, 73: 121-124. 10.1046/j.1445-2197.2003.02646.x.PubMed

The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/10/111/prepub

Title: Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy
Authors: Devidas Menon
Tania Stafinski
Heng Wu
Darren Lau
Clarence Wong
Publication date: 01-12-2010
Publisher: BioMed Central
Published in: BMC Gastroenterology / Issue 1/2010
Electronic ISSN: 1471-230X
DOI: https://doi.org/10.1186/1471-230X-10-111

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2010

Acute-on-chronic liver failure due to thiamazole in a patient with hyperthyroidism and trilogy of Fallot: case report

Rapid induction of orthotopic hepatocellular carcinoma in immune-competent rats by non-invasive ultrasound-guided cells implantation

Polymorphisms of genes coding for ghrelin and its receptor in relation to colorectal cancer risk: a two-step gene-wide case-control study

Laparoscopic and open resection for colorectal cancer: an evaluation of cellular immunity

The overmethylated genes in Helicobacter pylori-infected gastric mucosa are demethylated in gastric cancers

Moxibustion for ulcerative colitis: a systematic review and meta-analysis

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials